Postdoctoral Researcher in COVID-19, Molecular and Medical Pharmacology

University of California Los Angeles School of Medicine

United States

Postdoctoral Researcher, COVID-19, Molecular and Medical Pharmacology

Job #JPF05994
  • David Geffen School Of Medicin - MOLECULAR & MEDICAL PHARMACOLOGY

Recruitment Period

Open date: November 9th, 2020

Next review date: Tuesday, Dec 1, 2020 at 11:59pm (Pacific Time)
Apply by this date to ensure full consideration by the committee.

Final date: Monday, Jan 4, 2021 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.


The Department of Molecular and Medical Pharmacology at University of California, Los Angeles (UCLA) is looking to hire a postdoctoral fellow. The opening is intended for collaborative COVID-19 research working on identification of cellular therapeutic targets and the development of antiviral drugs. These projects are backed by stable NIH and DOD funding in collaboration with multi-disciplinary teams in UCLA hospital and Cedars Sinai Medical Center. The ideal candidate should have a Ph.D. degree in microbiology, molecular biology, biochemistry, or a related field. Previous experience with virus culture, digital PCR, next-generation sequencing, molecular assay development, or/and animal handling is highly desirable. Interested candidates should send a brief cover letter and curriculum vitae

Job location

Los Angeles, CA


Document requirements
  • Curriculum Vitae - Your most recently updated C.V.
  • Cover Letter
  • Statement of Research (Optional)
  • Statement of Teaching (Optional)
  • Statement on Contributions to Equity, Diversity, and Inclusion - An EDI Statement describes a faculty candidate’s past, present, and future (planned) contributions to equity, diversity, and inclusion. To learn more about how UCLA thinks about contributions to equity, diversity, and inclusion, please review our Sample Guidance for Candidates and related EDI Statement FAQ document.
  • (Optional)
  • Misc / Additional (Optional)

In your application, please refer to


amsterdam uni

antwerp uni

cambridge uni

florida uni

hamburg uni

harvard uni

hiroshima uni

oslo uni

purdue uni

ryerson uni

shanghai jiao tong uni

stockholm uni